GUARNERI, VALERIA
 Distribuzione geografica
Continente #
NA - Nord America 403
EU - Europa 210
AS - Asia 129
AF - Africa 19
OC - Oceania 1
Totale 762
Nazione #
US - Stati Uniti d'America 402
GB - Regno Unito 54
CN - Cina 52
SG - Singapore 50
SE - Svezia 41
IT - Italia 28
DE - Germania 25
IN - India 15
IE - Irlanda 14
BE - Belgio 9
RU - Federazione Russa 9
TG - Togo 8
FR - Francia 7
TR - Turchia 7
CI - Costa d'Avorio 5
FI - Finlandia 5
ZA - Sudafrica 5
EE - Estonia 4
UA - Ucraina 4
BG - Bulgaria 3
JO - Giordania 2
NL - Olanda 2
RS - Serbia 2
AT - Austria 1
AU - Australia 1
BB - Barbados 1
CH - Svizzera 1
EG - Egitto 1
GR - Grecia 1
HK - Hong Kong 1
ID - Indonesia 1
UZ - Uzbekistan 1
Totale 762
Città #
Singapore 47
Southend 47
Chandler 45
Ann Arbor 36
Fairfield 35
Santa Clara 31
Houston 28
Ashburn 19
Seattle 19
Wilmington 15
Boardman 14
Dublin 14
Woodbridge 13
Princeton 12
Cambridge 11
Bologna 9
Brussels 9
Lomé 8
Beijing 6
Falls Church 6
Turin 6
Abidjan 5
Ankara 5
Nanjing 5
Redmond 5
Westminster 5
Faenza 4
Jinan 4
Padova 4
Dearborn 3
Florence 3
Guangzhou 3
Lappeenranta 3
San Diego 3
Sofia 3
Amman 2
Amsterdam 2
Berlin 2
Bremen 2
Changsha 2
Falkenstein 2
Helsinki 2
Los Angeles 2
Mountain View 2
New York 2
Norwalk 2
Redwood City 2
Saint Petersburg 2
Shenyang 2
Xi'an 2
Zrenjanin 2
Acton 1
Athens 1
Bhubaneswar 1
Bridgetown 1
Bryanston 1
Bühl 1
Cairo 1
Central District 1
Costa Mesa 1
Erie 1
Foshan 1
Frankfurt Am Main 1
Fremont 1
Haikou 1
Harbin 1
Hebei 1
Hengyang 1
Istanbul 1
Jakarta 1
Jiaxing 1
London 1
Medford 1
Melbourne 1
Moscow 1
Nanchang 1
Oldham 1
Phoenix 1
Plauen 1
Pune 1
Qingdao 1
Rimini 1
Shijiazhuang 1
Taizhou 1
Tappahannock 1
Tianjin 1
Vienna 1
Washington 1
Totale 554
Nome #
The use of obeticholic acid for the management of non-viral liver disease: current clinical practice and future perspectives 152
Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods 126
Liver Stiffness improvement in subjects with advanced chronic hepatitis C treated with direct antiviral agents. 95
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 95
null 92
Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgery 73
Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment 58
Utility of neutrophil-to-lymphocyte ratio to identify long-term survivors among HCC patients treated with sorafenib 30
Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease 26
Symptoms of SARS-CoV-2 infection and vaccine status of sixty-seven adult patients affected by inherited metabolic diseases: a phone survey 18
Caloric input is inadequate in predicting the presence of liver steatosis and fibrosis in a population adhering to a screening program for metabolic syndrome 15
METABOLIC EFFECTS OF ANTI-HCV DIRECT ACTING ANTIVIRALS (DAA): A RETROSPECTIVE STUDY 13
Totale 793
Categoria #
all - tutte 2.567
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.567


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020101 0 0 0 0 0 19 24 18 18 7 5 10
2020/202171 21 4 7 1 1 5 4 4 7 5 4 8
2021/2022142 6 4 3 5 13 9 4 11 4 23 40 20
2022/2023170 13 33 5 22 12 13 7 7 34 6 14 4
2023/202467 3 10 4 7 4 6 0 11 3 10 0 9
2024/2025145 9 34 30 26 38 8 0 0 0 0 0 0
Totale 793